ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products
![Synaffix ABL Bio Partnership](https://wellnessnews24.com/wp-content/uploads/2023/09/pexels-cottonbro-studio-3952241-720x530.jpg)
2 min read
Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development...